Anders Gobl
Impact in
Papers in ⓘ
-
- Neuroblastoma Research and Treatments 9
- Oncology 10
- Lung Cancer Research Studies 4
- Cytokine Signaling Pathways and Interactions 2
- Cancer-related Molecular Pathways 2
- Co-authors
- Kjell Öberg (16 shared papers)Britt Skogseid (11 shared papers)Yinghua Zhou (8 shared papers)Gunnar Westin (2 shared papers)Catharina Larsson (4 shared papers)Jonas Rastad (4 shared papers)Mikael Berg (1 shared paper)Lars Hellman (1 shared paper)
In The Last Decade
Anders Gobl
19 papers receiving 573 citations
Peers
Comparison fields: 5 of 69
- Neurology 218
- Oncology 271
- Epidemiology 318
- Endocrinology, Diabetes and Metabolism 53
- Molecular Biology 192
Countries citing papers authored by Anders Gobl
This map shows the geographic impact of Anders Gobl's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Anders Gobl with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Anders Gobl more than expected).
Fields of papers citing papers by Anders Gobl
This network shows the impact of papers produced by Anders Gobl. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Anders Gobl. The network helps show where Anders Gobl may publish in the future.
Co-authors
The 25 scholars most cited alongside Anders Gobl, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1999 | 95 | |
| 2 | 1995 | 85 | |
| 3 | Expression of transforming growth factors beta 1, beta 2, beta 3 in neuroendocrine tumors of the digestive system. | 1995 | 62 |
| 4 | 2000 | 58 | |
| 5 | 1994 | 46 | |
| 6 | 1998 | 44 | |
| 7 | 2004 | 43 | |
| 8 | A comparison between the efficacy of somatostatin receptor scintigraphy and that of in situ hybridization for somatostatin receptor subtype 2 messenger RNA to predict therapeutic outcome in carcinoid patients. | 1996 | 38 |
| 9 | 2001 | 22 | |
| 10 | 2002 | 21 | |
| 11 | 2001 | 13 | |
| 12 | The induction of IFN-a and -b mRNA in human natural interferon producing blood leukocytes requires de novo protein synthesis | 1991 | 12 |
| 13 | 2000 | 11 | |
| 14 | In situ RNA-RNA hybridisation of phospholipase C beta 3 shows lack of expression in neuroendocrine tumours. | 2003 | 9 |
| 15 | 1999 | 8 | |
| 16 | 1995 | 7 | |
| 17 | 1997 | 6 | |
| 18 | Inhibition of CDK2, CDK4 and cyclin E and increased expression of p27Kip1 during treatment with interferon-a in carcinoid tumor cells | 1999 | 5 |
| 19 | 1998 | 4 |
About Anders Gobl
Anders Gobl is a scholar working on Neurology, Oncology, Epidemiology, Microbiology and Nephrology, having authored 19 papers that have together received 589 indexed citations. Recurring topics across this work include Neuroendocrine Tumor Research Advances (12 papers), Neuroblastoma Research and Treatments (9 papers), Lung Cancer Research Studies (4 papers), Cytokine Signaling Pathways and Interactions (2 papers), Cancer-related Molecular Pathways (2 papers), Protein Kinase Regulation and GTPase Signaling (2 papers), Microtubule and mitosis dynamics (1 paper) and Metabolism, Diabetes, and Cancer (1 paper). The work is most often cited by research in Neurology (218 citations), Oncology (271 citations), Epidemiology (318 citations), Endocrinology, Diabetes and Metabolism (53 citations) and Molecular Biology (192 citations). Anders Gobl has collaborated with scholars based in Sweden, Australia and Belarus. Frequent co-authors include Kjell Öberg, Britt Skogseid, Yinghua Zhou, Gunnar Westin, Catharina Larsson, Jonas Rastad, Mikael Berg, Lars Hellman, Magnus Åbrink and Peter Stålberg. Their work appears in journals such as FEBS Letters, Surgery, Endocrinology, Biochimica et Biophysica Acta (BBA) - Biomembranes and Human Molecular Genetics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.